Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-6-25
pubmed:abstractText
In ionotropic glutamate receptors, many channel properties (e.g., selectivity, ion permeation, and ion block) depend on the residue (glutamine, arginine, or asparagine) located at the tip of the pore loop (the Q/R/N site). We substituted a cysteine for the asparagine present at that position in both NR1 and NR2 N-methyl-D-aspartate (NMDA) receptor subunits. Under control conditions, receptors containing mutated NR1 and NR2 subunits show much smaller glutamate responses than wild-type receptors. However, this difference disappears upon addition of heavy metal chelators in the extracellular bath. The presence of cysteines at the Q/R/N site in both subunits of NR1/NR2C receptors results in a 220,000-fold increase in sensitivity of the inhibition by extracellular Zn. In contrast with the high-affinity Zn inhibition of wild-type NR1/NR2A receptors, the high-affinity Zn inhibition of mutated NR1/NR2C receptors shows a voltage dependence, which resembles very much that of the block by extracellular Mg. This indicates that the Zn inhibition of the mutated receptors results from a channel block involving Zn binding to the thiol groups introduced into the selectivity filter. Taking advantage of the slow kinetics of the Zn block, we show that both blocking and unblocking reactions require prior opening of the channel.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-10049997, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-10197535, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-10398755, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-10512812, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-1321496, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-1375397, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-1382314, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-1386653, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-1793004, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-2457089, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-3881765, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-5031113, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-7576654, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8041762, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8201981, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8210177, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8416947, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8630242, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8642401, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8710925, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8780657, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8815211, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-8880741, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9187268, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9221770, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9247273, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9481670, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9490808, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9525859, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9584213, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9698310, http://linkedlifedata.com/resource/pubmed/commentcorrection/11423399-9716133
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0006-3495
pubmed:author
pubmed:issnType
Print
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
107-16
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:11423399-Amino Acid Substitution, pubmed-meshheading:11423399-Animals, pubmed-meshheading:11423399-Binding Sites, pubmed-meshheading:11423399-Cysteine, pubmed-meshheading:11423399-Disulfides, pubmed-meshheading:11423399-Dose-Response Relationship, Drug, pubmed-meshheading:11423399-Electrochemistry, pubmed-meshheading:11423399-Oocytes, pubmed-meshheading:11423399-Patch-Clamp Techniques, pubmed-meshheading:11423399-Point Mutation, pubmed-meshheading:11423399-Protein Binding, pubmed-meshheading:11423399-Protein Structure, Secondary, pubmed-meshheading:11423399-Protein Subunits, pubmed-meshheading:11423399-Rats, pubmed-meshheading:11423399-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:11423399-Recombinant Proteins, pubmed-meshheading:11423399-Thermodynamics, pubmed-meshheading:11423399-Xenopus, pubmed-meshheading:11423399-Zinc
pubmed:year
2001
pubmed:articleTitle
High-affinity Zn block in recombinant N-methyl-D-aspartate receptors with cysteine substitutions at the Q/R/N site.
pubmed:affiliation
Laboratoire de Neurobiologie, Ecole Normale Supérieure, 75005 Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't